Will testosterone treatment in combination with a lifestyle program normalise glucose tolerance in men with either pre-diabetes or newly diagnosed type 2 diabetes, in comparison to placebo and a lifestyle program?
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 May 2017
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Glucose intolerance; Hypogonadism; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms T4DM
- 21 Apr 2017 Planned End Date changed from 31 Dec 2016 to 7 May 2019.
- 21 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2012 Planned initiation date changed from 1 Jul 2012 to 1 Sep 2012 as reported by Australian New Zealand Clinical Trials Registry.